h/m HOXA9 shRNA Lentivirus

SKU:BHV19400173
Catalog / Quick links
    Overview
    Click light‑blue chips for details
    The h/m HOXA9 shRNA Lentivirus provides validated, high-titer particles for stable knockdown of human and mouse HOXA9, a homeodomain transcription factor that drives hematopoietic progenitor self-renewal and is a recurrent oncogenic factor in acute myeloid leukemia. Delivering a U6-driven shRNA with fluorescent reporter and antibiotic selection, it efficiently transduces primary and difficult-to-transfect cells for reproducible loss-of-function studies in cancer research.
    Species Human, Mouse
    Target Gene HOXA9
    Reporter GFP, RFP, GFP/Luc (+1 more)
    Selection Blasticidin, Puromycin
    Accession NM_152739.4
    Validation ≥70% Knockdown Validated
    Format 3rd Gen, VSV-G Pseudotyped
    Available Options

    Select the lentiviral variant that best fits your experiment. Availability and lead time may vary by option.

    • Options:
      • Includes GFP reporter with Puromycin selection; supplied as 5x10^6 (sh-mix) + 5x10^6 (scr-mix) TU.
      • Includes RFP reporter with Blasticidin selection; supplied as 5x10^6 (sh-mix) + 5x10^6 (scr-mix) TU.
      • Includes GFP reporter with Puromycin selection; supplied as 5x10^6 TU.
      • Includes RFP reporter with Blasticidin selection; supplied as 5x10^6 TU.
    • Lead time: typically ships in ~7 business days; timing may vary by selected option.
    • Storage: store at -80°C
    • Shipping: Ships on dry ice
    • Upon receipt: follow the product datasheet storage instructions.
    • Sales terms and conditions: Please review prior to ordering.
    Options selector
    Catalog no. Reporter Selection Amount (TU)
    LSV-0058-SET1 GFP
    LSV-0058-SET2 RFP
    Field Specification
    Accession Number NM_152739.4
    Product Type
    • Lentiviral Vector
    • shRNA Lentivirus
    Reporter GFP, RFP, GFP/Luc, RFP/Luc, N/A
    Selection Marker Blasticidin, N/A, Puromycin
    Shipping Ships on dry ice; store at -80°C
    Species Human, Mouse

    Background

    HOXA9 (homeobox A9) is a homeodomain transcription factor belonging to the HOX family of master regulators of body patterning and tissue identity. In the hematopoietic system HOXA9 is highly expressed in immature progenitor cells, where it supports self-renewal and proliferation, and is normally downregulated as cells differentiate. Sustained or aberrant HOXA9 expression blocks differentiation and promotes the expansion of leukemic cells. HOXA9 overexpression is a recurrent feature of acute myeloid leukemia, frequently driven by chromosomal rearrangements involving MLL or by upstream regulators such as NUP98 fusions, and it is associated with poor prognosis. HOXA9 is therefore widely studied as a key oncogenic transcription factor in leukemia research.

    Product Description & Applications

    The h/m HOXA9 shRNA Lentivirus delivers a validated short hairpin RNA targeting human and mouse HOXA9 for stable, RNA interference-based gene silencing. The 19-20 bp shRNA is expressed from a U6 Pol III promoter within a third-generation, self-inactivating lentiviral backbone, with a constitutively expressed fluorescent reporter (GFP, GFP/Luc, RFP, RFP/Luc) and an antibiotic selection marker (Blasticidin or Puromycin) for tracking and stable line generation. VSV-G pseudotyping enables broad cell tropism, including primary, suspension, and cryopreserved cells. Knockdown is confirmed to meet or exceed 70% using a fluorescence-based assay. Particles are ultra-purified and concentrated by PEG precipitation and sucrose gradient centrifugation. Sets supply lentivirus from two independent shRNAs plus a scrambled-shRNA control, supporting loss-of-function studies of HOXA9 in leukemia and cell biology.

    About This Product

    This validated shRNA lentivirus targeting HOXA9 (NCBI Accession: NM_152739.4) delivers a 19–20 bp shRNA from a third-generation, self-inactivating lentiviral backbone. Expression is driven from a U6 Pol III promoter, with a constitutively expressed fluorescent reporter (GFP, RFP, GFP/Luc, RFP/Luc) and antibiotic selection marker (Blasticidin, Puromycin) co-expressed from the same vector. VSV-G pseudotyping enables broad cell tropism, including primary, suspension, and cryopreserved cell types.

    Knockdown is validated using a proprietary bicistronic fluorescence assay in which the target mRNA is co-expressed fused to RFP alongside the shRNA-GFP construct. At least 70% reduction in RFP signal in GFP-positive cells confirms on-target activity — a more direct functional readout than transcript-level qPCR. Polyclonal stable lines can be generated by antibiotic selection within 10 days, preserving parental cell heterogeneity compared to single-clone CRISPR approaches.

    What knockdown efficiency does this shRNA lentivirus achieve?
    How was the shRNA construct validated?
    What reporter and selection marker options are available?
    What cell types are recommended for transduction?
    Is a negative control lentivirus available?

    Can't find the lentiviral construct you need, or want to adjust key design elements? Contact us to discuss custom LV design and optional add-ons.

    Common customization requests

    • Insert / payload: replace the gene/sequence, swap to a different isoform, add mutations, or optimize cloning features.
    • Expression design: change promoter (e.g., CMV/EF1α/PGK), add enhancers, or adjust regulatory elements.
    • Reporters: add/swap GFP/RFP/mCherry/luciferase (single or dual reporters where applicable).
    • Selection markers: add/swap puromycin/blasticidin/neomycin or fluorescent selection options.
    • Vector format: switch between OE, shRNA, CRISPR (sgRNA/Cas systems), or control vectors (where supported).

    Add-ons you can request

    • Control viruses: empty vector, non-targeting shRNA, reporter-only controls, or matched backbone controls.
    • Packaging / format: concentration options, aliquoting, or custom fill volume for screening workflows.
    • Documentation: construct map/sequence confirmation package (as available) and batch documentation.

    What to include in your request

    • Target cell type/model (cell line or primary cells) and intended readout (reporter, knockdown, OE, etc.)
    • Insert sequence (FASTA) or reference ID, plus any required tags/mutations
    • Promoter, reporter, and selection marker preferences
    • Desired scale and preferred format (aliquots / concentration requests)

    Email us at support@biohippo.com or use the Talk to a Scientist request form.

    Research budgets are tight — we get it. That's why we've put together a fresh round of exclusive promotions designed to help you stock up on the reagents, kits, and consumables your lab depends on, without stretching your budget.

    🔬 What's on offer right now:

    10% Off Pre-Designed siRNA Sets

    20% Off Transmembrane Proteins

    $50 Off All ELISA Kits

    50% Off Lab Consumables + Free Shipping

    $99 Pipette Filler Promotion Package

    BlasTaq 2X qPCR MasterMix - 50% OFF Limited Time Offer

    DENARASE® Endonuclease — 10% Off One Order

    10% OFF CELL LINES-Limited-Time Offer

    Free Sample – CellTrypase Recombinant Trypsin-Like Enzyme

    Free Sample – MycoFold™ Growth Factors

    Get a Quote

    Please use this form for bulk quantity requests or customized products.

    Contact Information

    Product Information

    Try Celltrypse Free – Request Your Sample Today

    Experience the power of Celltrypse™, c-LEcta's innovative enzyme solution for gentle and efficient cell dissociation. Request your free sample and discover a superior alternative for your cell culture workflows.

    Try Celltrypse Free – Request Your Sample Today

    Try Celltrypse Free – Request Your Sample Today

    Experience the power of Celltrypse™, c-LEcta's innovative enzyme solution for gentle and efficient cell dissociation. Request your free sample and discover a superior alternative for your cell culture workflows.

    Try Celltrypse Free – Request Your Sample Today